Blueprint Medicines Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Blueprint medicines company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Blueprint Medicines Company Profile Today - Breaking & Trending Today

Avidity Partners Management LP Decreases Stake in Blueprint Medicines Co. (NASDAQ:BPMC)

Avidity Partners Management LP lessened its stake in Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 18.2% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 615,000 shares of the biotechnology company’s stock after selling 136,600 shares during the quarter. Blueprint Medicines accounts for approximately 2.1% of Avidity […] ....

United States , Piper Sandler , Ariel Hurley , Stifel Nicolaus , Michael Landsittel , Blueprint Medicines Co , Jump Financial , Securities Exchange Commission , Compass Wealth Management , Headlands Technologies , Blueprint Medicines Corporation , Blueprint Medicines Company Profile , Associates Corp , Avidity Partners Management , Blueprint Medicines , Free Report , Partners Management , Wealth Management , Management Fondsmaeglerselskab , Get Free Report , Exchange Commission , Medicines Corporation , Visit Holdingschannel , Blueprint Medicines Daily ,

Blueprint Medicines (NASDAQ:BPMC) Coverage Initiated at Stephens

Stephens assumed coverage on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a report published on Tuesday, MarketBeat.com reports. The firm issued an overweight rating and a $140.00 price objective on the biotechnology company’s stock. Other equities analysts have also issued research reports about the company. SVB Leerink raised Blueprint Medicines from an underperform […] ....

United States , Ariel Hurley , Piper Sandler , Michael Landsittel , Jacobs Levy Equity Management Inc , Blueprint Medicines Company Profile , Kennedy Capital Management , Bellevue Group , Redmile Group , Securities Exchange Commission , Goldman Sachs Group , Comerica Bank , Blueprint Medicines Corporation , Blueprint Medicines , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Levy Equity Management , Capital Management , Medicines Corporation , Blueprint Medicines Daily ,

Blueprint Medicines Co. (NASDAQ:BPMC) Short Interest Update

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average daily volume of 830,500 shares, […] ....

United States , Zurcher Kantonalbank Zurich Cantonalbank , Ariel Hurley , Kate Haviland , Allspring Global Investments Holdings , Blueprint Medicines Corporation , Mirae Asset Global Investments Co , Securities Exchange Commission , York Mellon Corp , Needham Company , Blueprint Medicines Company Profile , Blueprint Medicines Co , Blueprint Medicines , Get Free Report , Medicines Stock Down , Exchange Commission , New York Mellon Corp , Kantonalbank Zurich Cantonalbank , Asset Global Investments , Global Investments Holdings , Teacher Retirement System , Retirement System , Medicines Corporation , Blueprint Medicines Daily ,

Short Interest in Blueprint Medicines Co. (NASDAQ:BPMC) Grows By 6.8%

Blueprint Medicines Co. (NASDAQ:BPMC – Get Free Report) was the recipient of a significant growth in short interest in April. As of April 30th, there was short interest totalling 4,540,000 shares, a growth of 6.8% from the April 15th total of 4,250,000 shares. Based on an average trading volume of 830,500 shares, the days-to-cover ratio […] ....

United States , Christopherk Murray , Piper Sandler , Stifel Nicolaus , Blueprint Medicines Co , Needham Company , Principal Financial Group Inc , Us Bancorp , Associates Corp , Mirae Asset Global Investments Co , Blueprint Medicines Company Profile , Securities Exchange Commission , Canada Life Assurance , Blueprint Medicines Corporation , Blueprint Medicines , Get Free Report , Exchange Commission , Asset Global Investments , Financial Group , Medicines Stock Down , Medicines Corporation , Blueprint Medicines Daily ,

The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168.00

The Goldman Sachs Group Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $168.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , New Zealand General , New Zealand , Michael Landsittel , Jeffreyw Albers , Piper Sandler , Needham Company , Blueprint Medicines Corporation , Blueprint Medicines Company Profile , Securities Exchange Commission , Polar Capital Holdings Plc , Vanguard Group Inc , Goldman Sachs Group , Wellington Management Group , Blueprint Medicines , Free Report , Medicines Trading Down , Get Free Report , Director Jeffrey , Exchange Commission , Management Group , Springs Capital Management , Capital Holdings Plc , Avidity Partners Management , Partners Management , Medicines Corporation ,